Morning-after pills available at 13 NYC schools

September 24, 2012

(AP)—The New York City Department of Education is making the morning-after-pill available to high school girls at 13 public schools.

The DOE says girls as young as 14 will be able to get the Plan B emergency contraception without parental consent.

Parents have been notified about the CATCH and how their daughters can opt out of it.

City Council Speaker Christine Quinn says she supports the program because are sexually active and getting pregnant.

The city says about 7,000 girls get pregnant by the time they reach the age of 17. It says more than half choose to get an abortion.

NYC schools already distribute to students.

Explore further: US mulls easier access to emergency contraception

shares

Related Stories

US mulls easier access to emergency contraception

December 6, 2011
US regulators are considering whether to grant a drug company's request to make emergency contraception available over the counter to people of all ages instead of by prescription.

Recommended for you

With no morphine, 25 million die in pain each year: report

October 13, 2017
Every year, some 25 million people—one in ten of them children—die in serious pain that could have been alleviated with morphine at just a few cents per dose, researchers said Friday.

Study finds few restrictions on Rx opioids through Medicare

October 9, 2017
Medicare plans place few restrictions on the coverage of prescription opioids, despite federal guidelines recommending such restrictions, a new Yale study finds. The research results highlight an untapped opportunity for ...

Nocebo effect: Does a drug's high price tag cause its own side effects?

October 5, 2017
Pricey drugs may make people more vulnerable to perceiving side effects, a new study suggests—and the phenomenon is not just "in their heads."

Pre-packaged brand version of compounded medication to prevent preterm births costs 5,000 percent more

October 2, 2017
Preventing a preterm birth could cost as little as $200 or as much as $20,000, depending on which one of two medications a doctor orders, according to a new analysis from Harvard Medical School.

Cancer drugs' high prices not justified by cost of development, study contends

September 12, 2017
(HealthDay)— Excusing the sky-high price tags of many new cancer treatments, pharmaceutical companies often blame high research and development (R&D) costs.

Non-psychotropic cannabinoids show promise for pain relief

September 4, 2017
Some cancers love bone. They thrive in its nutrient-rich environment while gnawing away at the very substrate that sustains them, all the while releasing inflammatory substances that cause pain—pain so severe that opioids ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.